Brokerage Stocks Getting Hit With NYSE
If you looked at the brokerage firm stocks today, you’d have no idea the market was up. Morgan Stanley (MS), Merrill Lynch (MER), Bear Stearns (BSC), and Goldman Sachs (GS) are all down. They…
If you looked at the brokerage firm stocks today, you’d have no idea the market was up. Morgan Stanley (MS), Merrill Lynch (MER), Bear Stearns (BSC), and Goldman Sachs (GS) are all down. They…
CNBC’s Charlie Gasparino keyed in today on 2 potential takeout candidates today. His Street Stories Hank Greenberg may be engaged trying to buyout the ENTIRE New York Times (NYT) company. He said the controlling…
As far as where the NASDAQ trading volume interest is, it isn’t even close. The Horsemen stocks are chugging along at almost twice the share volume of the smaller cap traditional most active names…
Amazon trades pretty much in the middle of its three year range. The stock hit $60 in mid-2003. It sits around $40 now. Pacific Crest securities says that it is time to dump AMZN.…
Stocks: (GOOG) Google seems to take one step forward and two steps back in its dispute with content owners over whether they can post their headlines. Or, is that two steps forward and one…
Yesterday I keyed in about some concerns about 3Com (COMS) paying out $882 million for the other 49% of the Huawei joint venture called H3C. The buyout itself isn’t the big deal, but they…
(ABI) Abraxis Bio gets FDA approval for Amphicillin Injection.(AGN) Allergan up on Cramer from Mad Money.(AH) Armor Holdings wins another $53 million order for components.(ARNA) Arena filed to sell 8M shares of stock.(CHS) Chico’s…
ACV started as Neutral at Prudential.AMR started as Buya t Goldman Sachs.ANN cut to Neutral at UBS.BLDR started as Mkt Perform at JMP.BMHC started as Mkt Perform at JMP.BOBJ started as Equal Weight at…
Saudi Prince Walid first put money into Citi in 1991. The stock was at about $2 then and trades at closer to $50 now.The man is believed to be Citi’s largest shareholder. He should…
Merck’s stock price is fascinating The shares trade near their 52-week high, changing hands at almost $44. But, the company has tons of problems. The fact that Pfizer has just cuts its US sales…
From BioHealth Investor by Andrew Vaino Interesting article in yesterday’s San Diego Union Tribune bemoaning the offshoring of biotech research to cheaper labor markets. The article discusses the demise of Discovery Partners (formerly DPII),…
From BioHealth Investor Shares of Anika Therapeutics (ANIK) jumped more than 20% on Tuesday after the company announced it had received an approvable letter from the FDA regarding its Cosmetic Tissue Augmentation (CTA) product.…
From Volume Spike Investor Shares of Essex Corp.(KEYW) rose more than 1% on Tuesday as volume spiked 250% above the 3-month daily average. There were no significant news releases or other significant events that…
From The Average Joe Investor So I was watching Cramer last on Mad Money and heard his pitch on Allergan (NYSE: AGN). I liked it, liked it a lot. These days, though, it’s tough…
By Yaser Anwar, CSC of Equity Investment Ideas I happened to catch Mad Money last night where Cramer highlighted BAC’s Analyst David Strasser’s work on Lowe’s Corp (LOW). Called in a favor and got…
By Yaser Anwar, CSC of Equity Investment Ideas On October 2 06, HET received a proposal from Apollo and Texas Pacific Group to acquire all of HET’s outstanding common stock for $81 per share…
By William Trent, CFA of Stock Market Beat We have written often on the flat-panel market, where we are concerned that existing capacity and planned expansions will cut so deeply into prices that by…
By William Trent, CFA of Stock Market Beat WSTS projects semiconductor industry growth to peak in 2008 World Semiconductor Trade Statistics (WSTS) projects the global semiconductor industry will continue to grow in 2007 and…
By William Trent of Stock Market Beat Back when Morgan Stanley got excited about the Freescale buyout, we threw some cold water on the idea, saying “If you figure the average buyout will be…